Conference Menu

Overview
Register
Download Brochure
Posters
Hotel & Travel
Sponsor & Exhibit
Request Brochure
Archives 

Media Partners:

Biospace

Labroots 



Genetic Engineering News

PharmaVoice

Genomeweb Logo 

Future Science

Science AAAS

Nature

The Scientist


Targeting Mitochondrial Dysfunction & Toxicity Conference - Overview


Register by December 12 & SAVE up to $400! 


Mitochondrial failure and/or dysfunction has been identified as an important factor in diseases ranging from neurodegenerative conditions (ALS, Alzheimer’s, Parkinson’s Disease), epilepsy and autism, to diseases of the cardiovascular system, liver, and kidney, as well as cancer and diabetes.  The broad impact of mitochondria in so many diseases makes them prime targets for therapeutics.

Since medications for many diseases cause unwanted toxicity to the mitochondria, it is extremely critical for drug discovery and development researchers to be able to predict and prevent this serious side effect for their compounds.  This conference will present the latest research in new targeting pathways, novel therapeutics, and new breakthroughs in the understanding of mitochondrial function, as well as methods to decrease or eliminate mitochondrial toxicity when developing therapeutics. 

Topics to be covered may include (but are not limited to): 

  • Emerging research on mitochondrial function
  • Novel drug classes shown to target mitochondrial dysfunction
  • Existing drugs with newly discovered effects on mitochondria
  • New mitochondria imaging techniques

Therapeutic areas: 

  • Improving mitochondrial function
  • Neurodegenerative Disease
  • Cardiovascular Disease
  • Cancer
  • Diabetes
  • Diseases of Aging

Avoiding Mitochondrial Toxicity in Drug Development: 

  • Assays for determining mitochondrial toxicity
  • Methods to avoid mitochondrial toxicity in drugs
  • Strategies for reduction of toxicity

If you are interested in presenting, please submit a speaking proposal for review. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biotech companies, regulators and those from academic centers.  Additionally, per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Please submit your proposal here.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. 

Proposal Deadline:  September 5, 2014 

If you have questions, please contact: 
Elizabeth J. Lamb
Senior Conference Director
Cambridge Healthtech Institute
Ph:  781-247-6259
Email:  elamb@healthtech.com 



By Series:
By Region:


Conference
& Course Catalog

CHI Catalog 


Short Course DVDs